The potential of metformin for diabetes prevention

Diabetes and Metabolism

Volumn 29, Issue 4 II, 2003, Pages

  Slama, G ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Diabetes prevention; Impaired fasting glucose; Impaired glucose tolerance; Metformin; Type 2 diabetes

Indexed keywords

METFORMIN;

COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DOSE RESPONSE; DRUG TOLERABILITY; ECONOMIC ASPECT; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEALTH CARE COST; HUMAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PROPHYLAXIS; REVIEW; RISK FACTOR; TREATMENT PLANNING;

EID: 18144440465     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(03)72794-3     Document Type: Review

References (29)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 1998, 21, 1414-31.
2. Amos AF. McCarty DJ, Zimmet P. The rising global burden of diabetes and complications: estimates and projections to the year 2010. Diabet Med, 1997, 14 (suppl. 5), S1-S85.
3. Zimmet P, Alberti KGMM, Shaw 1. Global and societal implications of the diabetes Nature, 2001, 414, 782-7.
4. Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med., 2002, 19, 708-23.
5. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998, 352, 837-53.
6. World Health Organisation: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation 1999.
7. American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Diseases. Position statement: The prevention or delay of type 2 diabetes. Diabetes Care, 2002, 25, 742-8.
8. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL. Postchallenge hyperglycaemia and mortality in a national sample of U.S. adults. Diabetes Care, 2001, 24, 1397-402.
9. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the US Diabetes Care, 2001, 24, 447-53.
10. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002, 346, 393-403.
11. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998, 352, 854-65.
12. American Diabetes Association. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20, 1183-97.
13. Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 1999, 22, 623-34.
14. Diabetes Prevention Program Research Group. Effect of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care, 2003, 26, 977-80.
15. Hernan WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care, 2003, 26, 36-47.
16. Palmer AJ, Roze S, Comte S, Cabrières L. Cost-effectiveness of intensive lifestyle changes or metformin in overweight, glucose-intolerant patients: modelling the long-term implications of the diabetes prevention program in the French, German and UK settings [Abstract]. Diabetologia, 2002, 45 (suppl. 2), A303.
17. Wenying Y, Lixiang L, Jinwu Q, Guangwei L, Zhiqing Y, Xiaoren P. The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3-year multicentral prospective study. Chin J Endocrinol Metab, 2001, 17, 131-4.
18. Chiasson J-L, Josse RG. Gomis R, Hanefeld M, Karasik A, Laakso M, for the STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 2002, 359, 2072-7
19. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose can prevent type 2 diabetes and cardiovascular disease in subjects with impaired glucose tolerance: the STOP-NIDDM trial [Abstract]. Diabetologia 2002, 45 (suppl. 2), A104
20. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001, 344, 1343-50.
21. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care, 1997, 20, 537-44.
22. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med, 1999, 16, 716-30.
23. American Diabetes Association. Clinical Practice Recommendations. Diabetes Care, 1999, 22 (suppl. 1), S1-S114.
24. Hu FB, Leitzmann MF, Stampfer MJ, et al. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Int Med, 2001, 161, 1542-8.
25. Olivarius N, Beck-Nielsen H, Andreasen AH, Hørder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. Br Med J, 2001, 323, 1-9.
26. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003, 348, 383-93.
27. Activity Counseling Trial: a randomized controlled trial. JAMA, 2001, 286, 677-87.
28. Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care, 2001, 24, 619-24.
29. Mckay HG, King D. Eakin EG, Seeley JR, Glasgow RE. The Diabetes Network Internet-Based Physical Activity Intervention. A randomized pilot study. Diabetes Care, 2001, 24, 1328-34.